Annex III. Management of the main particular situations in the treatment with anti-TNF-alpha
Annales de dermatologie et de venereologie 134(12): 1008-1013
2007
ISSN/ISBN: 0151-9638 PMID: 18166929 Document Number: 611460
Document emailed within 1 workday
Related Documents
Katayama, H.; Kawada, A.; Endoh, C.; Hori, H.; Yoshikawa, K. 1983: Reduced excretion of the main urinary metabolite of prostaglandin F1 alpha and F2 alpha in psoriatic patients Acta Dermato-Venereologica 63(3): 233-235Andrisani, G.; Guidi, L.; Papa, A.; Armuzzi, A. 2012: Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease European Review for Medical and Pharmacological Sciences 16(7): 890-901
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Locht, H.; Pelck, R.; Manthorpe, R. 2008: Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome Journal of Rheumatology 35(5): 845-849
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Hamon, M.A.; Nicolas, G.; Deviere, F.; Letournel, F.; Dubas, F. 2007: Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature Revue Neurologique (Paris) 163(12): 1232-1235
Yamamoto-Furusho, J.K.; Bosques-Padilla, F.; Alberro, M.; Armienta, R.; Bernal, Rúl.; Bielsa, Mía.Victoria.; Blas, M.; Bosques, F.; Charúa, L.; Cortés, Tás.; de Ariño, M.; Lira, M.Antonio.; Malé, Ré.; Orozco, A.; Manauta, J.Pérez.; Noble, A.; Ramos, M.; Raña, R.; Rivera, J.; Rocha, Jé.Luis.; Rojas, Més.; Tamayo, Jé.Luis.; Teramoto, O.; Uscanga, L.Federico.; Vásquez, E.; Yamamoto Furusho, K.; Zárate, A.Rosa. 2009: Mexican consensus on the use of agents anti-TNF-alpha in the treatment of inflammatory bowel disease. Revista de Gastroenterologia de Mexico 74(3): 263-278
Théroux, P.; Chaitman, B.R.; Danchin, N.; Erhardt, L.; Meinertz, T.; Schroeder, J.S.; Tognoni, G.; White, H.D.; Willerson, J.T.; Jessel, A. 2000: Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators Circulation 102(25): 3032-3038
Van Lieshout, A.W.T.; Creemers, M.C.W.; Radstake, T.R.D.J.; Elving, L.D.; van Riel, P.L.C.M. 2008: Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha Journal of Rheumatology 35(5): 938-939
Seriolo, B.; Paolino, S.; Ferrone, C.; Cutolo, M. 2008: Impact of long-term anti-TNF-alpha treatment on insulin resistance in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 26(1): 159-60; author reply 160
Stohrer, R.; Lee, M.C.; Kearney, J.F. 1983: Analysis of the anti-alpha 1 leads to 3 dextran response with monoclonal anti-idiotype antibodies Journal of Immunology 131(3): 1375-1379
2007: Annex. Statistical procedures Protein and Amino Acid Requirements in Human Nutrition: Report of a 935: 259-265
Salomon, F. 1987: Responsible decisions: a guideline for situations in intensive medical management Der Anaesthesist 36(3): 97-101
Bakinovskiĭ, L.V.; Gomtsian, A.R.; Baĭramova, N.E.; Kochetkov, N.K. 1985: Synthesis of oligosaccharide fragments of O-specific polysaccharides of Shigella flexneri. III. Synthesis of the tetrasaccharide Glc alpha 1-3Rha alpha 1-2(Glc alpha 1-3)Rha alpha 1-OMe and the pentasaccharide GlcNAc beta 1-2(Glc alpha 1-3)Rha alpha 1-2(Glc alpha 1-3)Rha alpha 1-OMe Bioorganicheskaia Khimiia 11(5): 655-661
Maksymowych, W.P.; Inman, R.D.; Gladman, D.; Thomson, G.; Stone, M.; Karsh, J.; Russell, A.S. 2003: Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis Journal of Rheumatology 30(6): 1356-1363
Makowska, Z. 1995: Stress management: individual differences and determination of situations (review of studies) Medycyna Pracy 46(4): 395-406
Beaugerie, L. 2001: Acute diarrhea in the adult. Diagnostic orientation and management in emergency situations La Revue du Praticien 51(8): 917-923
Delbes, C.; Gaymu, F.J. 2005: Situations matrimoniales et ménages des personnes âgées : quelles évolutions ? : Les nouvelles données démographiques - Matrimonial situations and household among older people: which development? Retraite et Societe (Paris) (45): 69-87
Matsuda, J.; Saitoh, N.; Gotoh, M.; Gohchi, K.; Tsukamoto, M.; Syoji, S.; Miyake, K.; Yamanaka, M. 1995: High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha American Journal of Gastroenterology 90(7): 1138-1141
Padillo, F.J.; Cruz, A.; Segura-Jiménez, I.; Ruiz-Rabelo, J.; Vázquez-Ezquerra, M.R.; Perea-Alvarez, M.D.; Peña, J.; Briceño, J.; Muntané, J. 2007: Anti-TNF-alpha treatment and bile duct drainage restore cellular immunity and prevent tissue injury in experimental obstructive jaundice International Journal of Immunopathology and Pharmacology 20(4): 855-860